These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36621732)

  • 1. Tau-aggregation inhibitors derived from Streptomyces tendae MCCC 1A01534 protect HT22 cells against okadaic acid-induced damage.
    Liu X; She W; Sung HH; Williams ID; Qian P
    Int J Biol Macromol; 2023 Mar; 231():123170. PubMed ID: 36621732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors.
    Shi CJ; Peng W; Zhao JH; Yang HL; Qu LL; Wang C; Kong LY; Wang XB
    Eur J Med Chem; 2020 Feb; 187():111961. PubMed ID: 31865017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirror-Image Phage Display for the Selection of D-Amino Acid Peptide Ligands as Potential Therapeutics.
    Malhis M; Funke SA
    Curr Protoc; 2024 Feb; 4(2):e957. PubMed ID: 38372457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro.
    Aillaud I; Kaniyappan S; Chandupatla RR; Ramirez LM; Alkhashrom S; Eichler J; Horn AHC; Zweckstetter M; Mandelkow E; Sticht H; Funke SA
    Alzheimers Res Ther; 2022 Jan; 14(1):15. PubMed ID: 35063014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
    Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration.
    Gabr MT; Peccati F
    ACS Chem Neurosci; 2020 Jul; 11(14):2051-2057. PubMed ID: 32579329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells.
    Shen XY; Luo T; Li S; Ting OY; He F; Xu J; Wang HQ
    Int J Mol Med; 2018 Feb; 41(2):1138-1146. PubMed ID: 29207020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptotanshinone Attenuates Amyloid-β
    Lyu D; Jia J
    Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Fibers from the Tau Model AcPHF6 by Naturally Occurring Aurones and Synthetic Analogues.
    Lunven L; Bonnet H; Yahiaoui S; Yi W; Da Costa L; Peuchmaur M; Boumendjel A; Chierici S
    ACS Chem Neurosci; 2016 Jul; 7(7):995-1003. PubMed ID: 27225823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation.
    Wasiak T; Ionov M; Nieznanski K; Nieznanska H; Klementieva O; Granell M; Cladera J; Majoral JP; Caminade AM; Klajnert B
    Mol Pharm; 2012 Mar; 9(3):458-69. PubMed ID: 22206488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid.
    Yao J; Gao X; Sun W; Yao T; Shi S; Ji L
    Biochemistry; 2013 Mar; 52(11):1893-902. PubMed ID: 23442089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer disease hyperphosphorylated tau aggregates hydrophobically.
    Ruben GC; Ciardelli TL; Grundke-Iqbal I; Iqbal K
    Synapse; 1997 Nov; 27(3):208-29. PubMed ID: 9329157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
    Chou CH; Yang CR
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β-Derived Peptidomimetics Inhibits Tau Aggregation.
    Gorantla NV; Sunny LP; Rajasekhar K; Nagaraju PG; Cg PP; Govindaraju T; Chinnathambi S
    ACS Omega; 2021 May; 6(17):11131-11138. PubMed ID: 34056268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Inhibits Tau Aggregation In Vitro.
    Alali S; Riazi G; Ashrafi-Kooshk MR; Meknatkhah S; Ahmadian S; Hooshyari Ardakani M; Hosseinkhani B
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature's toolbox against tau aggregation: An updated review of current research.
    Khan S; Hassan MI; Shahid M; Islam A
    Ageing Res Rev; 2023 Jun; 87():101924. PubMed ID: 37004844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents.
    Monteiro KLC; Alcântara MGDS; de Aquino TM; da Silva-Júnior EF
    Curr Pharm Des; 2020; 26(15):1682-1692. PubMed ID: 32286939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the inhibitory effects of liquiritigenin against tau fibrillation and related neurotoxicity as a model of preventive care in Alzheimer's disease.
    Yuan X; Wang Z; Zhang L; Sui R; Khan S
    Int J Biol Macromol; 2021 Jul; 183():1184-1190. PubMed ID: 33965487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory Effects of Isobavachalcone on Tau Protein Aggregation, Tau Phosphorylation, and Oligomeric Tau-Induced Apoptosis.
    Xiao S; Wu Q; Yao X; Zhang J; Zhong W; Zhao J; Liu Q; Zhang M
    ACS Chem Neurosci; 2021 Jan; 12(1):123-132. PubMed ID: 33320518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau/Aβ chimera peptides: A Thioflavin-T and MALDI-TOF study of Aβ amyloidosis in the presence of Cu(II) or Zn(II) ions and total lipid brain extract (TLBE) vesicles.
    Sciacca MFM; Di Natale G; Milardi D; Pappalardo G
    Chem Phys Lipids; 2021 Jul; 237():105085. PubMed ID: 33895131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.